Kisspeptin and Hematologic Parameters as Predictive Biomarkers for First-Trimester Abortions
Open Access
- 1 January 2021
- journal article
- research article
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 36 (2) , 98-105
Abstract
Objective: Spontaneous abortion is the most common complication of early pregnancy, affecting up to 20% of recognized pregnancies. Kisspeptin is predominantly released by placental syncytiotrophoblasts, and regulates their placental invasion into the uterine matrices. We aimed to establish an association of serum kisspeptin levels with pregnancy outcomes during the early gestational stage of the first trimester. Method: In this prospective study, 90 pregnant women in their 7 to 8 6/7 gestational weeks were classified into three groups: (i) The control group, consisting of healthy pregnant women (n=30), (ii) the threatened abortion group (n=30), and (iii) the spontaneous abortion group (n=30). The maternal serum samples were analyzed for complete blood count parameters and kisspeptin levels. Results: There was no statistical difference regarding body mass index (BMI) and gestational age (p=0.370). Regarding detailed obstetric notations, including gravida, parity, abortion, and living children, socioeconomic levels, and employment rates, all study groups were comparable (p>0.05, for all). No significant association was found regarding the biochemical parameters of complete blood count, including neutrophil, lymphocyte, and platelet concentrations, as well as neutrophil-to-lymphocyte ratios (NLR) and platelet-to-lymphocyte ratios (PLR) (p>0.05, for all). The median serum kisspeptin levels of the study groups did not differ between the groups (p=0.153). Correlation analysis revealed no significant relationship between serum kisspeptin levels and other study parameters in any study groups (p>0.05, for all) Conclusions: We found no statistically significant relationship between serum kisspeptin concentrations and pregnancy outcomes in the early gestational stage of the first trimester, and serum kisspeptin concentrations did not seem to be a reliable marker to distinguish abortion status from viable pregnancyKeywords
This publication has 36 references indexed in Scilit:
- The Differential Expression of Kiss1, MMP9 and Angiogenic Regulators across the Feto-Maternal Interface of Healthy Human Pregnancies: Implications for Trophoblast Invasion and Vessel DevelopmentPLOS ONE, 2013
- Altered placental expression of kisspeptin and its receptor in pre-eclampsiaJournal of Endocrinology, 2012
- Plasma Kisspeptin Levels in Pregnancies with Diabetes and Hypertensive Disease as a Potential Marker of Placental Dysfunction and Adverse Perinatal OutcomeEndocrine Research, 2011
- Association of kisspeptin-10 levels with abortus imminens: a preliminary studyArchives of Gynecology and Obstetrics, 2011
- Decreased serum levels of kisspeptin in early pregnancy are associated with intra‐uterine growth restriction and pre‐eclampsiaPrenatal Diagnosis, 2009
- Differential ovarian expression of KiSS‐1 and GPR‐54 during the estrous cycle and photoperiod induced recrudescence in Siberian hamsters (Phodopus sungorus)Molecular Reproduction and Development, 2008
- Decreased plasma levels of metastin in early pregnancy are associated with small for gestational age neonatesPrenatal Diagnosis, 2008
- Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblastsJournal of Cell Science, 2004
- The Metastasis Suppressor Gene KiSS-1 Encodes Kisspeptins, the Natural Ligands of the Orphan G Protein-coupled Receptor GPR54Journal of Biological Chemistry, 2001
- KiSS-1 Represses 92-kDa Type IV Collagenase Expression by Down-regulating NF-κB Binding to the Promoter as a Consequence of IκBα-induced Block of p65/p50 Nuclear TranslocationJournal of Biological Chemistry, 2001